Global Digital Audit 2026
Market Intelligence.
Without Borders.
We analyze real demand, competition, regulation and buying behavior across the most vibrant economies of Ibero-America. Every report ends in a decision: where to enter, how, and with what offer.
Request my auditMeasured demand
Search volume, trends and seasonality by procedure and country.
Mapped competition
Who dominates the market, with what offer, at what price, with what funnel.
Regulation & barriers
Accreditations, homologation and entry requirements per territory.
Reports by market
The central insight of each territory, distilled from our analysis of digital ecosystems, demand and competition.
Mexico
#1 hub in the AmericasMexico already operates as a global aesthetic tourism hub, driven by scale, accessibility and strong international demand. It is the continent’s top destination for aesthetic procedures targeting US and Canadian patients.
Demand & origin
Mexico is the continent’s top receiver of international patients: per data compiled by Global Healthcare Accreditation, it exceeded 1.3 million patients annually before the pandemic, focused on bariatric, dental, aesthetics and orthopedics. The driver is structural: the US corridor combines price differential, proximity and a diaspora that normalizes medical travel.
Competition
Competition is the densest in the region: Tijuana, Cancun and Mexico City concentrate clinics with US-style commercial machinery (bilingual call centers, financing, aggressive remarketing). Cost per click on bariatric and dental campaigns for US audiences is among the highest in the category. Competing without a speed-and-follow-up system is donating budget.
Winning position
The opportunity is no longer "being cheap": it is verifiable trust (accreditation, named surgeons, documented outcomes) and end-to-end coordinated experience. The US patient compares three Mexican clinics before deciding; the one that answers first and removes the most friction wins, not the one that discounts hardest.
Regulation & trust
COFEPRIS regulates practice; international accreditation (JCI, GHA) and medical travel association membership work as trust filters for the US buyer. English-language records and consents are de facto standard for the corridor.
Strategic read
A volume market in an attention war: entering without differentiation is expensive. Recommended entry: dominate one procedure and one city with closed-price offers and instant-response systems before expanding.
Brazil
Global leaderBrazil leads the global plastic surgery market as a hub of aesthetic innovation and international technical reference. Its procedure volume and cultural influence define global standards of beauty and surgical practice.
Demand & origin
Brazil is the global technical reference in plastic surgery: it disputes the world’s highest aesthetic procedure volume year after year and trains surgeons for the whole region. GHA recorded ~250,000 international patients annually pre-pandemic, low relative to its potential: the market is huge but historically domestic-oriented.
Competition
Domestic competition is fierce and sophisticated in personal branding (surgeon-influencers were born here), but international commercial infrastructure (multilingual, travel logistics, remote follow-up) remains the exception. Few clinics run a serious English-language funnel.
Winning position
The "Brazilian plastic surgery" brand is an under-used global asset. For US and European patients, the winning message combines Brazilian technical authority with international coordination standards that almost nobody offers today: that is the gap.
Regulation & trust
ANVISA and regional medical councils regulate practice; the real barrier for international patients is language and logistics rather than legal. English documentation and remote post-op support are the operational differentiators.
Strategic read
World-class technical authority with an immature international funnel: the asymmetry favors whoever first builds English-language acquisition infrastructure with full travel coordination.
Colombia
Body surgery leaderColombia positions itself as a results-driven aesthetic hub, internationally recognized for its specialization in body procedures and transformational surgery, combining surgical expertise, modern infrastructure and highly competitive costs.
Demand & origin
Colombia consolidated an international reputation in body procedures and transformational surgery, with Medellin, Cali and Bogota as hubs. Demand comes from the US (including the diaspora), Central America and the Caribbean, drawn by surgical expertise plus competitive costs.
Competition
High density of surgeons with strong personal brands on social; organic content (before/after, video) is the competitive currency. The gap is systems: response speed, serious qualification of international leads and documented travel coordination remain minority practices.
Winning position
Against the safety stigma that regional competitors exploit, the winning play is over-transparency: published safety protocols, verifiable accreditations, consented documented cases and an explicit post-op process.
Regulation & trust
INVIMA and health secretariats regulate; after high-profile unsafe surgery cases, the country tightened control over aesthetic clinics. For international patients, institutional safety signals (licensing + accreditation) weigh more than ever.
Strategic read
A market with a powerful organic engine and weak commercial systems: whoever professionalizes capture (speed + verification + logistics) converts category reputation into their own patients.
Spain
Gateway to the EUSpain emerges as the regulated premium alternative in global aesthetic tourism: European healthcare standards, highly qualified specialists and consolidated lifestyle destinations attracting patients from Europe and Latin America.
Demand & origin
Spain is the regulated premium alternative of Spanish-speaking aesthetic tourism: EU healthcare standards, elite surgeons and lifestyle destinations (Madrid, Barcelona, Marbella) enabling combined travel. It attracts European patients who won’t leave the EU regulatory framework and high-income Latin American patients.
Competition
Domestic competition is strong in traditional medical branding but conservative in digital acquisition: few run funnels with instant response and packaged offers. The real price competitor is Turkey; Spain cannot and should not fight that war.
Winning position
The winning position is "regulated premium": European legal certainty, clinical traceability and destination experience. For European patients the message is proximity + EU guarantees versus the perceived risk of low-cost destinations.
Regulation & trust
Full EU framework: GDPR for data, regional health regulation, exhaustive consents. The regulatory burden is higher, and precisely because of that it is a sales asset against destinations without that umbrella.
Strategic read
Do not compete on price: compete on certainty. Premium packaged offers with EU guarantees and modern acquisition have an open gap, because incumbents own the brand but not the system.
Chile
Emerging hubChile combines unique conditions to become an emerging international aesthetic tourism hub: OECD-comparable medical quality, a safe and stable environment, and a premium destination experience still globally under-exploited.
Demand & origin
Chile combines OECD-comparable medical quality with a safe, stable environment, yet its inbound medical tourism volume remains marginal relative to potential: a market to build, not to conquer. Regional demand (Bolivia, Peru, Argentina) arrives organically today, with almost nobody capturing it systematically.
Competition
International competition is nearly nonexistent: elite clinics compete for high-income domestic patients and do not operate international funnels. The first serious operator of the regional corridor will define the category.
Winning position
The winning narrative is "OECD quality at Latin American prices in the region’s most stable country". For high-income Andean patients, Chile can be what Houston is for elite Mexican patients: the standard of seriousness.
Regulation & trust
Robust health system supervised by the Superintendencia de Salud; private clinics with high standards and mature national accreditation processes that ease the jump to international accreditation.
Strategic read
A virgin market with first-rate fundamentals: acquisition cost is low because nobody competes yet. A 2-3 year window to build the reference position before the category gets expensive.
Costa Rica
Wellness + recoveryCosta Rica emerges as a patient-experience-centered aesthetic tourism hub: certified procedures integrated with wellness recovery and natural destinations, with a differentiated proposition oriented to the US market.
Demand & origin
Costa Rica built a clear niche: experience-centered medical tourism where procedures integrate with wellness recovery in natural settings. GHA recorded ~100,000 patients annually pre-pandemic, mostly from the US, in dental, aesthetics and bariatric.
Competition
A mature, collaborative ecosystem (clinics, recovery hotels, facilitators) but boutique in scale. Competition for US dental and aesthetic patients is solid though less commercially aggressive than Mexico’s.
Winning position
The differential is not price (Mexico wins that war): it is the complete recovery experience. The winning offer packages procedure + wellness recovery + nature with a calm-and-safety narrative, for patients willing to pay more to feel cared for.
Regulation & trust
Ministry of Health + international accreditations present among leading players. Political stability and the "pura vida" country brand reduce US patients’ trust friction.
Strategic read
A defensible premium-experience niche: do not try to win on volume; win on ticket and margin with complete recovery packages aimed at experience-seeking US patients.
Argentina
Technical expertiseArgentina positions itself as an aesthetic market led by medical expertise and technical sophistication, excelling in non-surgical treatments and natural results, increasingly attractive to patients who prioritize professional quality.
Demand & origin
Argentina stands out for medical expertise and technical sophistication, particularly strong in non-surgical treatments and natural results. The currency differential makes it periodically attractive to regional and European patients, though volatility complicates stable pricing.
Competition
Buenos Aires concentrates a mature aesthetic scene, clinically competitive but with underdeveloped international digital acquisition: most live off domestic patients and word of mouth.
Winning position
The play is "technical sophistication + natural results" for patients fleeing the artificial look, with dollarized, closed prices that absorb volatility. Offer stability is itself a differentiator in this market.
Regulation & trust
ANMAT and professional councils regulate; the real operational challenge is economic: pricing, international collections and planning under inflation. Solving the payment rail is part of the product.
Strategic read
Elite talent with an immature international funnel in a volatile context: an opportunity for whoever packages certainty (closed USD pricing, guaranteed scheduling) on top of existing technical excellence.
Peru
Emerging marketPeru positions itself as an emerging aesthetic tourism market driven by economic accessibility, accelerating patient volume growth and a transition toward greater regulation and professionalization of the sector.
Demand & origin
Peru is an emerging market in transition: economic accessibility, accelerating patient volume growth and sector professionalization still underway. International demand is incipient, mostly regional and diaspora-driven.
Competition
Fragmented competition, few players with international accreditation and basic digital acquisition. The commercial entry barrier is low; the trust barrier is high.
Winning position
The early play is institutionality: visible accreditation, published protocols and documented cases. In a professionalizing market, the first operator that looks institutional captures the category’s trust (and margin).
Regulation & trust
DIGEMID/DIRIS supervise; the sector is moving toward more regulation. Anticipating tomorrow’s regulatory standard is a positioning advantage today.
Strategic read
An early-cycle bet: low entry cost, medium-term return. Interesting as the second market of a regional portfolio, not as a single bet.
For organizations · Enterprise
Do you know where your acquisition spend dies?
Ads are running. Leads are arriving. And a material share of budget dies somewhere between the click and the patient seated in consultation. In most healthcare organizations, even nine-figure ones, nobody can draw that path end to end. And what nobody can draw, nobody can fix.
For hospital groups and enterprise organizations we run in-depth diagnostics of the acquisition system: where the money is lost, why, and what should exist instead. Discreet, rigorous, and presented at executive level.
Request a diagnosticWhich market holds your next patient?
The full audit answers where to enter, who you compete against and which offer wins. Twenty minutes, with data on screen.
Book a free audit